Frontlight ResearchEarly access
Trial site
Care Access - Huntington Beach
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Obesity3 trials
- Alzheimer disease2 trials
- Type 2 diabetes2 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Osteoarthritis1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Phase
- Phase 35 trials
- Status
- Active, not recruiting4 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026